Researchers Submit Patent Application, "Treatment Of Sos2 Related Diseases And Disorders", for Approval (USPTO 20230407299).

A patent application has been submitted for the treatment of diseases and disorders related to SOS2. The application describes compositions comprising an oligonucleotide that targets SOS2 and, when administered to a subject, can improve various health measurements such as glomerular filtration rate, blood pressure, blood urate levels, and liver function. The oligonucleotide can be in the form of small interfering RNA (siRNA) or antisense oligonucleotide (ASO), and may contain modified internucleoside linkages or nucleosides. This treatment has potential applications for chronic kidney disease, diabetic nephropathy, gout, hypertension, obesity, and other conditions. [Extracted from the article]

Copyright of Gene Therapy Weekly is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)